409 related articles for article (PubMed ID: 30353299)
1. Calcitriol treatment in patients with low vitamin D levels.
Tanakol R; Gül N; Üzüm AK; Aral F
Arch Osteoporos; 2018 Oct; 13(1):114. PubMed ID: 30353299
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China.
Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
Medicine (Baltimore); 2018 Aug; 97(31):e11694. PubMed ID: 30075569
[TBL] [Abstract][Full Text] [Related]
3. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
[TBL] [Abstract][Full Text] [Related]
4. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).
Kärkkäinen M; Tuppurainen M; Salovaara K; Sandini L; Rikkonen T; Sirola J; Honkanen R; Jurvelin J; Alhava E; Kröger H
Osteoporos Int; 2010 Dec; 21(12):2047-55. PubMed ID: 20204604
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis.
Park SY; Kang MI; Park HM; Rhee Y; Moon SH; Yoon HK; Koh JM; Chang JS; Kim IJ; Won YY; Park YS; Choi H; Shin CS; Yoon TR; Yun SC; Chung HY;
Arch Osteoporos; 2019 Dec; 15(1):3. PubMed ID: 31820121
[TBL] [Abstract][Full Text] [Related]
6. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D
Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
BMC Musculoskelet Disord; 2018 Jul; 19(1):210. PubMed ID: 29970059
[TBL] [Abstract][Full Text] [Related]
7. Physical performance and life quality in postmenopausal women supplemented with vitamin D: a two-year prospective study.
Gao LH; Zhu WJ; Liu YJ; Gu JM; Zhang ZL; Wang O; Xing XP; Xu L
Acta Pharmacol Sin; 2015 Sep; 36(9):1065-73. PubMed ID: 26279157
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.
Hansen KE; Johnson RE; Chambers KR; Johnson MG; Lemon CC; Vo TN; Marvdashti S
JAMA Intern Med; 2015 Oct; 175(10):1612-21. PubMed ID: 26237520
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of cholecalciferol and calcitriol on calcium metabolism and bone turnover in Chinese postmenopausal women with vitamin D insufficiency.
Zhang H; Huang QR; Gu JM; Hu WW; Liu YJ; Hu YQ; Zhang ZL
Acta Pharmacol Sin; 2012 Apr; 33(4):490-5. PubMed ID: 22407227
[TBL] [Abstract][Full Text] [Related]
10. The effect of cholecalciferol and calcitriol on biochemical bone markers in HIV type 1-infected males: results of a clinical trial.
Bang UC; Kolte L; Hitz M; Schierbeck LL; Nielsen SD; Benfield T; Jensen JE
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):658-64. PubMed ID: 23199009
[TBL] [Abstract][Full Text] [Related]
11. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT.
Lima GL; Paupitz JA; Aikawa NE; Alvarenga JC; Pereira RMR
Osteoporos Int; 2018 Mar; 29(3):587-594. PubMed ID: 29152675
[TBL] [Abstract][Full Text] [Related]
13. Relationship between increased endogenous parathormone levels and bone density in postmenopausal women treated with bisphosphonates.
Coin A; Veronese N; Bolzetta F; De Rui M; Manzato E; Sergi G
Panminerva Med; 2012 Dec; 54(4):277-82. PubMed ID: 23123579
[TBL] [Abstract][Full Text] [Related]
14. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D insufficiency does not affect response of bone mineral density to alendronate.
Antoniucci DM; Vittinghoff E; Palermo L; Black DM; Sellmeyer DE
Osteoporos Int; 2009 Jul; 20(7):1259-66. PubMed ID: 19043656
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
Sakai A; Ito M; Tomomitsu T; Tsurukami H; Ikeda S; Fukuda F; Mizunuma H; Inoue T; Saito H; Nakamura T;
Osteoporos Int; 2015 Mar; 26(3):1193-202. PubMed ID: 25592133
[TBL] [Abstract][Full Text] [Related]
17. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women.
Park JH; Park KH; Cho S; Choi YS; Seo SK; Lee BS; Park HS
Menopause; 2013 Jul; 20(7):747-53. PubMed ID: 23511701
[TBL] [Abstract][Full Text] [Related]
18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
19. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.
van den Bout-van den Beukel CJ; van den Bos M; Oyen WJ; Hermus AR; Sweep FC; Tack CJ; Bosch ME; Burger DM; Koopmans PP; van der Ven AJ
HIV Med; 2008 Oct; 9(9):771-9. PubMed ID: 18754805
[TBL] [Abstract][Full Text] [Related]
20. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]